Sarna

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sarna
Generic name: PRAMOXINE HYDROCHLORIDE
Manufacturer: Crown Laboratories
Product type: HUMAN OTC DRUG
SPL set ID: 19b0ce1b-e147-01a1-e063-6394a90af808
SPL ID: 48341fc1-10ea-47fa-e063-6394a90abe32
Version: 5
Effective date: 2026-01-12
Source export date: 2026-10-27
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/6f51a1483736359ffd78ed7be27289bc51f2a8463b934465bee40efbdef4dfd7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 21:08:32

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 15 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Sarna	openfda.brand_name
generic name		PRAMOXINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Crown Laboratories	openfda.manufacturer_name
ndc	package	0316-0230-57	openfda.package_ndc
ndc	package	0316-0230-25	openfda.package_ndc
ndc	package	0316-0230-12	openfda.package_ndc
ndc	product	0316-0230	openfda.product_ndc
ndc11	package	00316023012	derived:openfda.package_ndc
ndc11	package	00316023057	derived:openfda.package_ndc
ndc11	package	00316023025	derived:openfda.package_ndc
rxcui		1246075	openfda.rxcui
spl id		48341fc1-10ea-47fa-e063-6394a90abe32	id
spl set id		19b0ce1b-e147-01a1-e063-6394a90af808	set_id
unii		88AYB867L5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use in the eyes over large areas of the body for prolonged periods When using this product avoid contact with eyes if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. Stop use and ask a doctor if redness, irritation, swelling, or pain persists or increases. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.